China Precision Medicine Market

Executive Summary (3/4)
Description
Precision medicine broadly inculcates a specified study of
patient information for the diagnosis and characterization
of a wide variety of diseases, resulting in target-based
treatment of diseases.
The era of precision medicine can be said to have arrived
and is rapidly growing within the healthcare community
through tremendous expansion in various advanced
technologies, such as next-generation sequencing (NGS),
biomarker analysis, and big data analytics.
China, being an emerging economy, has tapped into the
multi-faceted approach to patient care involved in precision
medicine.
Healthcare providers in China to avoid adverse drug
reactions, improve methods of administration, focus efforts
on prevention and earlier intervention, increase treatment
options, and most importantly, improve the quality of life,
as outlined in majority of its political agendas.
Figure 2.1: China Precision Medicine Market Value Share (%),
By Ecosystem – 2019 (E)
Analysis
XX.X%
XX.X%
Applied Sciences
Precision Therapeutics
Digital Health and Information
Technology (DHIT)
Precision Diagnostics
By Ecosystem, the applied sciences is accounted for major
value share XX.X% in 2019. Precision Therapeutics is
accounted for the second highest value share XX.X% in
2019 in the target market.
Source: Prophecy Market Insights
Copyright © PROPHECY MARKET INSIGHTS 2019, All Rights Reserved
5